Acarous Gray Positions 2023 Drug Law as Legacy Achievement of Weah Administration. In a significant political development surfacing in Monrovia on August 1, 2026, former Montserrado County District 8 Representative Acarous Moses Gray has reignited the debate over the legal legacy of the George Manneh Weah administration. The focal point of this resurgence is the Controlled Drugs and Substances Act of 2023, a piece of legislation that has become the bedrock of Liberia’s current efforts to curb a burgeoning narcotics crisis. Gray, a vocal stalwart of the Congress for Democratic Change (CDC), utilized social media to claim that recent supportive remarks from Executive Protection Service (EPS) Director Sam Gaye serve as a definitive, albeit perhaps unintentional, validation of the Weah administration's dedication to national security and judicial reform.
The crux of Gray's argument is that the current administration of President Joseph Nyuma Boakai relies heavily on tools crafted by its predecessor, even while frequently critiquing the past regime's performance. The legislation in question, which fundamentally overhauled Chapter 14 of the Liberian Penal Law, introduced rigorous punitive measures including classifying trafficking, manufacturing, and the large-scale importation of illicit substances as non-bailable first-degree felonies. Furthermore, it empowered the state with the authority to initiate the forfeiture of assets derived from or linked to drug-related illicit activities, a move intended to dismantle the financial infrastructure of organized crime syndicates. Liberia’s history with narcotics has been fraught with challenges that predate the current century.
Following the devastating civil wars that concluded in 2003, the nation struggled to reintegrate thousands of disenfranchised youth, many of whom became vulnerable to the influx of illicit substances. For years, Liberia served primarily as a transit point for narcotics flowing from South America toward European markets. However, the nature of this threat evolved under the administrations of Ellen Johnson Sirleaf and George Weah, as local consumption rates surged, particularly regarding the use of ‘kush’ and other synthetic drugs that have plagued urban centers like Monrovia. By the time the Weah administration took office in 2018, the drug epidemic was increasingly viewed as a national security emergency.
Gray asserts that the 2023 legislation was the culmination of long-term strategic planning by the CDC-led government. He emphasizes that the previous political establishment, which governed for a cumulative twelve-year period, failed to enact such stringent non-bailable provisions for major drug crimes. According to Gray, the inaction of those prior years left a legal vacuum that emboldened cartels, whereas the Weah administration took the necessary, albeit politically taxing, steps to close the loopholes in the Penal Code. The rhetoric surrounding this issue is deeply embedded in the broader political climate of Liberia, where the transition of power in 2024 has led to intense scrutiny of the successes and failures of the Weah era.
When Sam Gaye, a figure associated with the current security apparatus, signaled approval or reliance upon the efficacy of the 2023 law, it provided Gray with a tactical opening. For Gray, this is a matter of historical record; he argues that the current government’s reliance on this specific law implies that the legislative efforts of the previous parliament were robust, well-intentioned, and effective. The contention is not merely about the text of the law, but about the political capital required to pass such controversial measures. Gray reminds his audience that he, along with other key members of the former ruling coalition, played a central role in the drafting, sponsorship, and advocacy required to ensure the bill moved through the Legislature.
By highlighting this, he is effectively crafting a narrative that portrays the Weah administration as the true guardian of Liberia’s legal stability. This posture is also intended to contrast with the current performance of the Boakai administration. President Boakai, who campaigned on a promise to restore the rule of law and tackle corruption and crime, has faced persistent criticism from the opposition regarding the pace of his government’s legislative agenda. Gray specifically accused the Boakai government of failing to fulfill its own campaign promises to further strengthen the anti-drug framework.
This criticism suggests that while the current administration is happy to utilize the legislative tools provided by the Weah era, it has yet to innovate or expand upon those foundations in a meaningful way. This point is critical because it frames the Weah administration not just as a temporary pause in political continuity, but as a period of genuine legislative innovation that continues to bear fruit for the current leadership. The debate also highlights the broader structural difficulties Liberia faces in drug enforcement. Even with the 2023 law, the efficacy of the judicial system remains a significant hurdle.
Critics of the current enforcement process point out that a law is only as strong as the judiciary that interprets it and the police force that investigates it. There have been reports of sluggish trials, difficulties in gathering evidence, and the potential for corruption to influence the outcomes of major drug cases. Gray’s challenge to Director Gaye—to publicly acknowledge the Weah administration's role—is as much about public relations as it is about history. By forcing a dialogue about who truly authored the anti-drug architecture of the country, Gray is repositioning the CDC in the public consciousness as a proactive, security-focused political entity.
The implications of this are significant for the lead-up to future electoral cycles. As Liberians continue to grapple with the social costs of drug abuse, the narrative of who 'got tough on drugs' will be a powerful tool for political mobilization. Furthermore, the mention of the forfeiture of property as a component of the 2023 law adds a layer of complexity to the argument. Forfeiture laws are notoriously difficult to implement in jurisdictions where land titles and asset registries are informal or opaque.
The fact that the Weah administration secured the passage of such a law speaks to a bold legislative ambition that Gray is now keen to underline. He posits that if the law is being used effectively today, it is because of the foresight shown in 2023. As the nation watches the implementation of these anti-drug measures, the discourse surrounding their origins will undoubtedly continue to divide political factions. For the supporters of the former President, the 2023 Act stands as a testament to a governance style that was willing to confront difficult social issues with concrete legal mandates.
For the detractors, these arguments may seem like a redirection from other perceived failures during the Weah administration’s tenure. Regardless of the political lens, the Controlled Drugs and Substances Act remains a central pillar of the Liberian state’s response to a crisis that shows no signs of abating. The fact that an EPS Director’s comments could trigger such a vigorous defense of a previous regime’s legacy highlights the high stakes of legislative credit in the modern Liberian landscape. Gray’s intervention serves to solidify the 2023 law as a hallmark of his party’s time in power, ensuring that even as the political winds shift, the legislative contributions of that era remain firmly in the conversation.
By demanding recognition for these contributions, he is effectively claiming ownership of the current policy trajectory, framing the government as a beneficiary of the CDC’s foresight. This intellectual battle over the legacy of the anti-drug laws will likely persist as long as the law remains the primary instrument for addressing the illicit narcotics trade within the borders of Liberia.
